South San Francisco, CA, May 18, 2023 - Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a development-stage biopharmaceutical company today announced that its 505(b)(2) new drug application (NDA)..... We are a development-stage biopharmaceutical..
Relevance: 20.47191